| | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H14N2 |
| Molar mass | 174.247 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
6-(2-Aminopropyl)indole (6-API, 6-IT) is an indole derivative which was first identified being sold on the designer drug market by a laboratory in the Czech Republic in July 2016. [2]
Alexander Shulgin says in his book TiHKAL "From the normal 3-position to the 2, the 4, the 5, the 6 or the 7-positions. All five alpha-methyltryptamine isomers are known, but only one is known to be active in man as a CNS active material. This is the 5-isomer, 5-(2-aminopropyl)indole or 5-IT".
Studies in dogs have shown the drug to increase hemoglobin levels in the bloodstream. [3]
PAGE 503
| Adamantanes | |
|---|---|
| Adenosine antagonists | |
| Alkylamines | |
| Ampakines | |
| Arylcyclohexylamines | |
| Benzazepines | |
| Cathinones |
|
| Cholinergics |
|
| Convulsants | |
| Eugeroics | |
| Oxazolines | |
| Phenethylamines |
|
| Phenylmorpholines | |
| Piperazines | |
| Piperidines |
|
| Phenethylpyrrolidines | |
| Racetams | |
| Psychedelics | |
| Tropanes |
|
| Tryptamines | |
| Others |
|
| DRAs Tooltip Dopamine releasing agents |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRAs Tooltip Norepinephrine releasing agents |
| ||||||||||||||
| SRAs Tooltip Serotonin releasing agents |
| ||||||||||||||
| Others |
| ||||||||||||||
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||